Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 22% ± 4% | |
| epithelial cell | 5 studies | 28% ± 6% | |
| astrocyte | 4 studies | 23% ± 7% | |
| oligodendrocyte | 4 studies | 20% ± 4% | |
| classical monocyte | 3 studies | 19% ± 3% | |
| GABAergic neuron | 3 studies | 40% ± 5% | |
| glutamatergic neuron | 3 studies | 52% ± 7% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 6% | |
| macrophage | 3 studies | 19% ± 3% | |
| basal cell | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 38% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5101.80 | 1445 / 1445 | 100% | 24.46 | 183 / 183 |
| prostate | 100% | 5514.56 | 245 / 245 | 100% | 24.60 | 502 / 502 |
| stomach | 100% | 4642.88 | 359 / 359 | 100% | 18.59 | 286 / 286 |
| lung | 100% | 6520.30 | 578 / 578 | 100% | 21.42 | 1154 / 1155 |
| breast | 100% | 5565.87 | 459 / 459 | 100% | 31.33 | 1117 / 1118 |
| uterus | 100% | 5815.38 | 170 / 170 | 100% | 22.04 | 458 / 459 |
| intestine | 100% | 5377.04 | 966 / 966 | 100% | 18.30 | 525 / 527 |
| brain | 99% | 3549.01 | 2627 / 2642 | 100% | 20.77 | 705 / 705 |
| thymus | 100% | 5605.38 | 653 / 653 | 99% | 20.99 | 601 / 605 |
| ovary | 100% | 4245.07 | 180 / 180 | 99% | 15.02 | 427 / 430 |
| pancreas | 100% | 2935.43 | 327 / 328 | 99% | 18.07 | 177 / 178 |
| bladder | 100% | 5208.29 | 21 / 21 | 99% | 17.46 | 498 / 504 |
| skin | 100% | 6256.18 | 1809 / 1809 | 99% | 19.96 | 465 / 472 |
| kidney | 100% | 4100.54 | 89 / 89 | 98% | 18.82 | 884 / 901 |
| liver | 100% | 3601.56 | 226 / 226 | 97% | 14.62 | 393 / 406 |
| adrenal gland | 100% | 6791.22 | 258 / 258 | 96% | 15.16 | 221 / 230 |
| adipose | 100% | 5720.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5828.61 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 19.73 | 29 / 29 |
| spleen | 100% | 7940.71 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 24.16 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.97 | 1 / 1 |
| muscle | 100% | 2748.28 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 3148.73 | 853 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 5671.57 | 910 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 93% | 12.69 | 74 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0036211 | Biological process | protein modification process |
| GO_0006508 | Biological process | proteolysis |
| GO_0005829 | Cellular component | cytosol |
| GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FBXW2 |
| Protein name | F-box and WD repeat domain containing 2 (cDNA FLJ53609, highly similar to F-box/WD repeat protein 2) F-box and WD repeat domain containing 2 F-box/WD repeat-containing protein 2 (F-box and WD-40 domain-containing protein 2) (Protein MD6) Alternative protein FBXW2 |
| Synonyms | FBW2 FWD2 |
| Description | FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. |
| Accessions | B4DT60 ENST00000453291.2 Q9UKT8 ENST00000608872.6 [Q9UKT8-1] ENST00000684001.1 [Q9UKT8-1] L8EAL9 Q4VXH1 ENST00000684047.1 [Q9UKT8-1] ENST00000684405.1 |
